Get the Daily Brief
Latest Biotech News
New AI Algorithm Predicts Cardiovascular Risk Using Mammograms
Researchers at The George Institute for Global Health have developed an artificial intelligence model that accurately predicts cardiovascular disease risk in women by analyzing standard mammogram...
aTyr Pharma’s Efzofitimod Falls Short in Phase 3 Pulmonary Sarcoidosis Trial
Biotech company aTyr Pharma announced that its lead candidate efzofitimod did not meet the primary endpoint in a Phase 3 study evaluating steroid tapering efficacy in patients with pulmonary...
Breakthrough in Neuroscience Maps Brain Circuits Driving Visual Illusions
A collaborative study between University of California, Berkeley and the Allen Institute has identified a subset of neurons in the primary visual cortex that specifically encode illusory...
Mount Sinai Unveils NIH-Funded Virtual Cancer Center and AI-Powered Research Lab
Mount Sinai Comprehensive Cancer Center received a $1.7 million Department of Defense grant to support the Convergent Science Virtual Cancer Center, aiming to innovate oncology research and...
Lila Sciences Raises $235 Million to Build AI-Powered Autonomous Research Labs
Flagship Pioneering-backed startup Lila Sciences announced a $235 million Series A funding round to accelerate the development of AI-driven autonomous laboratories aimed at transforming drug...
GLP-1 Weight-Loss Drugs Face Regulatory and Market Scrutiny Amid Influential Direct-To-Consumer Advertising
GLP-1-based weight-loss medications, promoted both by pharma companies with careful regulatory compliance and by telehealth providers through direct-to-consumer campaigns, face contrasting...
FDA Approves Biocartis-BMS MSI Test for Colorectal Cancer Precision
Biocartis has secured FDA premarket approval for its Idylla CDx MSI test, developed in partnership with Bristol Myers Squibb. This automated, cartridge-based test rapidly identifies microsatellite...
Novartis and Monte Rosa Expand $5.7B Molecular Glue Immune Drug Partnership
Novartis has broadened its collaboration with Monte Rosa Therapeutics by licensing an exclusive molecular glue degrader targeting an undisclosed protein for immune-mediated diseases. The deal...
aTyr Pharma’s Efzofitimod Fails Phase III Pulmonary Sarcoidosis Trial
aTyr Pharma’s lead drug candidate efzofitimod missed the primary endpoint in a pivotal phase III trial aiming to reduce oral corticosteroid use in patients with pulmonary sarcoidosis. While the...
China Adds Three Biotech Firms to U.S. Export Control Entity List
The U.S. Department of Commerce’s Bureau of Industry and Security updated the Export Administration Regulations to designate 32 new entities including three Chinese biotechnology companies—Beijing...
Lila Sciences Raises $235M Series A to Build AI-Powered Autonomous Labs
Flagship Pioneering-backed Lila Sciences secured $235 million in Series A funding to advance its vision of scientific superintelligence, integrating artificial intelligence into autonomous...
Innovative AI-Enhanced CRISPR Assistant Accelerates Gene Therapy Research
Stanford Medicine researchers developed CRISPR-GPT, an artificial intelligence copilot designed to assist gene-editing experiment design and execution. By integrating AI into CRISPR workflows,...
AllRock Bio Launches with $65M Series A Focusing on Severe Lung Diseases
AllRock Bio, founded by former CinCor Pharma executives, emerged from stealth with a $65 million Series A to advance a small molecule pan-ROCK inhibitor licensed from Sanofi. The drug candidate...
Carolina Molecular Partners with Astoriom for Molecular Testing and Biobanking
Carolina Molecular announced a strategic partnership with Astoriom to integrate advanced molecular testing services with specialized biospecimen storage solutions. This collaboration offers life...
Boston University Secures $4.5M NIH Grant for Women's Health Research
Boston University received a significant $4.5 million National Institutes of Health grant via the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program. This five-year...
Bioprocess 5.0: Integrating AI and Automation to Scale Next-Generation Therapies
Industry leaders from Cytiva and Merck KGaA highlight the emergence of Bioprocess 5.0, a new era combining artificial intelligence, advanced automation, and sustainability to enhance biologics and...
Novartis Extends Protein Degrader Partnership: $5.7 Billion Deal with Monte Rosa Therapeutics
Novartis has deepened its collaboration with Monte Rosa Therapeutics by securing exclusive rights and options on molecular glue degraders for immune-mediated diseases in a deal valued at up to...
Phase 3 Setback for aTyr Pharma’s Efzofitimod in Pulmonary Sarcoidosis
aTyr Pharma’s lead drug candidate efzofitimod failed to meet its primary endpoint in a Phase 3 trial for pulmonary sarcoidosis, an inflammatory lung disease. The trial measured reduction in...
Lila Sciences Raises $235M Series A to Build AI-Driven Autonomous Research Labs
Flagship Pioneering’s Lila Sciences secured $235 million in Series A funding to develop scientific superintelligence by integrating advanced artificial intelligence into laboratory research...
Deep Learning Toolkit Flexynesis Advances Precision Oncology via Multi-Omics Integration
Researchers at the Max Delbrück Center released Flexynesis, a deep learning toolkit that integrates diverse multi-omics datasets and clinical information to improve diagnosis, prognosis, and...